Seal Rock Therapeutics
- Biotech or pharma, therapeutic R&D
As a clinical-stage biotechnology company, Seal Rock is developing a portfolio of internally discovered and developed kinase inhibitors for neurodegenerative diseases and chronic inflammatory and fibrotic liver diseases. Seal Rock’s most advanced program
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}